Frazier Life Sciences Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $16.1M | Hold |
|
|||||
|
2024
Q1 | $16.6M | Hold |
|
|||||
|
2023
Q4 | $16.7M | Hold |
|
|||||
|
2023
Q3 | $8.58M | Hold |
|
|||||
|
2023
Q2 | $12.5M | Hold |
|
|||||
|
2023
Q1 | $9.59M | Hold |
|
|||||
|
2022
Q4 | $12.4M | Hold |
|
|||||
|
2022
Q3 | $11.1M | Buy |
|
|||||
|
2022
Q2 | $5.35M | Buy |
|
|||||
|
2022
Q1 | $1.96M | Buy |
|